Tirzepatide Cost in Massachusetts (2026)

Tirzepatide pricing across Massachusetts

Covered like everywhere the pharmacies are licensed:

If you're pricing tirzepatide in Massachusetts, ignore the clinic quotes first and check the telehealth floor: verified compounded programs run $215–$597 a month all-in at 10 mg statewide, identical in Boston, Worcester, and every town between.

Every program we track is telehealth-first, so geography inside Massachusetts is irrelevant to price: intake happens online, the prescription goes to a pharmacy licensed for the state, and the medication ships cold-chain to Boston, Springfield, or anywhere else in 3–7 days. Brick-and-mortar med-spas around Worcester commonly charge $425–$750/month for equivalent compounded product.

One program makes the Massachusetts comparison short: NexLife’s $215/month is the lowest all-in figure we can verify anywhere, it’s flat from 2.5 to 15 mg, it bundles the consult, nutrition support, and expedited shipping, it publishes 50-state availability, and it names its six-pharmacy 503A/503B network. Commit 3, 6, or 12 months and the rate steps to $195, $190, or $186; its semaglutide sits at $145–$165.

Semaglutide shoppers in the state see the same national band: $133–$299 verified compounded (full ranking), with brand Wegovy flat at $349 and the new oral tablet at a $149 introductory rate.

From Cambridge to Lowell, availability tracks pharmacy licensure rather than metro size, so the smaller Massachusetts towns see the same prices and the same 3–7-day delivery as Boston.

Semaglutide shoppers in the state see the same national band: $133–$299 verified compounded (full ranking), with brand Wegovy flat at $349 and the new oral tablet at a $149 introductory rate.

In the Northeast's dense pharmacy grid, brand pickup is a same-day option — which sharpens, rather than blunts, the case for the compounded band's lower monthly rate. Twelve-month math favors the flat programs: the verified floor annualizes to $2,580 with zero lock-in, versus prepaid alternatives from about $2,028 with money committed up front — the trade priced on the annual-cost page.

Every figure above carries a capture date in the downloadable dataset; confirm at checkout — this market reprices monthly, in Massachusetts exactly as everywhere.

City by city

Boston. Nothing local moves the number — a Boston ZIP gets the same $215 verified floor, the same named-pharmacy options, and the same 3–7-day shipping as the rest of Massachusetts; what Boston does add is retail convenience for the brand fallback, with $449 Zepbound KwikPens at chain counters since March 2026.

Worcester. Med-spa and clinic quotes around Worcester commonly land at $425–$750/month for compounded product; the telehealth board serves the same molecule from $215 all-in, and the delta is pure delivery model, not medicine.

Springfield. For Springfield shoppers the practical checklist is short: confirm the program ships to your ZIP (they do, statewide), confirm the maintenance-dose price in writing, and benchmark any local quote against the $215 floor before signing anything.

Cambridge. Cambridge illustrates the state pattern in miniature — identical telehealth pricing to every smaller Massachusetts town, plus dense pharmacy access that makes the brand retail route a same-day fallback when a compounded program stumbles.

Lowell. Massachusetts’s search demand for GLP-1s concentrates here, and the answer is the statewide one: intake online, $425–$750/month-range local clinics undercut by the $215 telehealth floor, cold-chain delivery in 3–7 days to any Lowell address.

The semaglutide option statewide

Massachusetts shoppers pricing semaglutide instead face a friendlier band: $133–$299 verified compounded all-in. led by Oak Longevity at $133 (flat, no subscription), NexLife at $145 on a 12-month plan ($165 month-to-month; $149/$147 mid-terms; microdose from $129), and Yucca at $146 — all shipping statewide. Wegovy’s flat $349 (with $149–$199 intro offers) is the uniform brand benchmark in every Massachusetts ZIP — the ranking page has the field.

Brand-name access in Massachusetts

The FDA-approved route is state-uniform and increasingly practical: Zepbound at $299–$449 via LillyDirect — and, since March 2026, KwikPens at retail counters including Walmart across Massachusetts at the same tiers — roughly $350 on TrumpRx, and about a $50 monthly copay for newly eligible Medicare patients under the mid-2026 Part D expansion. Keep the ~45-day refill cadence or LillyDirect’s pricing lapses to $599–$1,049; the brand guide covers every channel.

Using insurance in Massachusetts

Before any cash number on this page, run the coverage check: with a commercial plan plus manufacturer savings card, covered copays run as low as $25/month; roughly 43% of large employers now include weight-loss medication (re-check every open enrollment); and the indication side doors — Wegovy’s cardiovascular indication, Zepbound’s sleep-apnea indication, any diabetes diagnosis — route around “weight loss excluded” language for Massachusetts patients with the qualifying condition. The playbook, including the appeal that works: the coverage guide.

What a Massachusetts year costs

Annualized at standing rates, the verified compounded tirzepatide board runs $2,580–$7,164 for year one — the floor being NexLife’s $2,580 with zero lock-in — against prepaid effectives from about $2,028 (Found) and $2,232 (NexLife’s 12-month tier), Wegovy’s $4,188 flat year, and Zepbound’s ~$5,188 standard-titration first year. Full annual math per program: the 12-month cost page.